These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3398840)

  • 21. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene.
    Stevens AM; Yu-Lee LY
    Mol Endocrinol; 1994 Mar; 8(3):345-55. PubMed ID: 8015552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirement of Sp1 and estrogen receptor alpha interaction in 17beta-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression.
    Li C; Briggs MR; Ahlborn TE; Kraemer FB; Liu J
    Endocrinology; 2001 Apr; 142(4):1546-53. PubMed ID: 11250935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Pit-1 phosphorylation mutant can mediate both basal and induced prolactin and growth hormone promoter activity.
    Fischberg DJ; Chen XH; Bancroft C
    Mol Endocrinol; 1994 Nov; 8(11):1566-73. PubMed ID: 7877625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription.
    Ambrosino C; Cicatiello L; Cobellis G; Addeo R; Sica V; Bresciani F; Weisz A
    Mol Endocrinol; 1993 Nov; 7(11):1472-83. PubMed ID: 8114761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
    Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G
    Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.
    Kraus WL; Montano MM; Katzenellenbogen BS
    Mol Endocrinol; 1993 Dec; 7(12):1603-16. PubMed ID: 8145766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential promoter usage in prolactin receptor gene expression: hepatocyte nuclear factor 4 binds to and activates the promoter preferentially active in the liver.
    Møldrup A; Ormandy C; Nagano M; Murthy K; Banville D; Tronche F; Kelly PA
    Mol Endocrinol; 1996 Jun; 10(6):661-71. PubMed ID: 8776726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stat 5b and the orphan nuclear receptors regulate expression of the alpha2-macroglobulin (alpha2M) gene in rat ovarian granulosa cells.
    Dajee M; Fey GH; Richards JS
    Mol Endocrinol; 1998 Sep; 12(9):1393-409. PubMed ID: 9731707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional domains of the human vitamin D3 receptor regulate osteocalcin gene expression.
    McDonnell DP; Scott RA; Kerner SA; O'Malley BW; Pike JW
    Mol Endocrinol; 1989 Apr; 3(4):635-44. PubMed ID: 2542779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
    Castillo AI; Aranda A
    Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-mediated induction of rat prolactin gene transcription requires the formation of a chromatin loop between the distal enhancer and proximal promoter regions.
    Gothard LQ; Hibbard JC; Seyfred MA
    Mol Endocrinol; 1996 Feb; 10(2):185-95. PubMed ID: 8825558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deoxyribonucleic acid response element-dependent regulation of transcription by orphan nuclear receptor estrogen receptor-related receptor gamma.
    Sanyal S; Matthews J; Bouton D; Kim HJ; Choi HS; Treuter E; Gustafsson JA
    Mol Endocrinol; 2004 Feb; 18(2):312-25. PubMed ID: 14645497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the intronic promoter of rat estrogen receptor alpha gene, responsible for truncated estrogen receptor product-1 expression.
    Schausi D; Tiffoche C; Thieulant ML
    Endocrinology; 2003 Jul; 144(7):2845-55. PubMed ID: 12810539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gene encoding chinook salmon (Oncorhynchus tschawytscha) prolactin: gene structure and potential cis-acting regulatory elements.
    Xiong F; Chin RA; Hew CL
    Mol Mar Biol Biotechnol; 1992 Apr; 1(2):155-64. PubMed ID: 1308811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
    Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family.
    Gourdou I; Gabou L; Paly J; Kermabon AY; Belair L; Djiane J
    Mol Endocrinol; 1996 Jan; 10(1):45-56. PubMed ID: 8838144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
    Coleman DT; Chen X; Sassaroli M; Bancroft C
    Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconstitution of protein kinase A regulation of the rat prolactin promoter in HeLa nonpituitary cells: identification of both GHF-1/Pit-1-dependent and -independent mechanisms.
    Rajnarayan S; Chiono M; Alexander LM; Gutierrez-Hartmann A
    Mol Endocrinol; 1995 Apr; 9(4):502-12. PubMed ID: 7659093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.